197 related articles for article (PubMed ID: 18384884)
1. Normal development and function of dendritic cells in mice lacking IDO-1 expression.
de Faudeur G; de Trez C; Muraille E; Leo O
Immunol Lett; 2008 Jun; 118(1):21-9. PubMed ID: 18384884
[TBL] [Abstract][Full Text] [Related]
2. Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions.
Onodera T; Jang MH; Guo Z; Yamasaki M; Hirata T; Bai Z; Tsuji NM; Nagakubo D; Yoshie O; Sakaguchi S; Takikawa O; Miyasaka M
J Immunol; 2009 Nov; 183(9):5608-14. PubMed ID: 19843945
[TBL] [Abstract][Full Text] [Related]
3. Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells.
Manlapat AK; Kahler DJ; Chandler PR; Munn DH; Mellor AL
Eur J Immunol; 2007 Apr; 37(4):1064-71. PubMed ID: 17343295
[TBL] [Abstract][Full Text] [Related]
4. The immunoregulatory role of IDO-producing human dendritic cells revisited.
Terness P; Chuang JJ; Opelz G
Trends Immunol; 2006 Feb; 27(2):68-73. PubMed ID: 16406698
[TBL] [Abstract][Full Text] [Related]
5. IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells.
Hill M; Tanguy-Royer S; Royer P; Chauveau C; Asghar K; Tesson L; Lavainne F; Rémy S; Brion R; Hubert FX; Heslan M; Rimbert M; Berthelot L; Moffett JR; Josien R; Grégoire M; Anegon I
Eur J Immunol; 2007 Nov; 37(11):3054-62. PubMed ID: 17948274
[TBL] [Abstract][Full Text] [Related]
6. Are indoleamine-2,3-dioxygenase producing human dendritic cells a tool for suppression of allogeneic T-cell responses?
Löb S; Ebner S; Wagner S; Weinreich J; Schäfer R; Königsrainer A
Transplantation; 2007 Feb; 83(4):468-73. PubMed ID: 17318080
[TBL] [Abstract][Full Text] [Related]
7. Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes.
Ueno A; Cho S; Cheng L; Wang J; Hou S; Nakano H; Santamaria P; Yang Y
Diabetes; 2007 Jun; 56(6):1686-93. PubMed ID: 17360980
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO.
Krause P; Singer E; Darley PI; Klebensberger J; Groettrup M; Legler DF
J Leukoc Biol; 2007 Nov; 82(5):1106-14. PubMed ID: 17698915
[TBL] [Abstract][Full Text] [Related]
9. Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock.
Jung ID; Lee MG; Chang JH; Lee JS; Jeong YI; Lee CM; Park WS; Han J; Seo SK; Lee SY; Park YM
J Immunol; 2009 Mar; 182(5):3146-54. PubMed ID: 19234212
[TBL] [Abstract][Full Text] [Related]
10. High-affinity uptake of kynurenine and nitric oxide-mediated inhibition of indoleamine 2,3-dioxygenase in bone marrow-derived myeloid dendritic cells.
Hara T; Ogasawara N; Akimoto H; Takikawa O; Hiramatsu R; Kawabe T; Isobe K; Nagase F
Immunol Lett; 2008 Feb; 116(1):95-102. PubMed ID: 18179826
[TBL] [Abstract][Full Text] [Related]
11. [Echinococcus granulosus recombinant antigen B induced IDO expression in mouse bone marrow-derived dendritic cells in vitro].
Shan JY; Ji WZ; Tursun T; Li L; Zhang CS; Lin RY; Wen H
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2011 Apr; 29(2):111-6. PubMed ID: 21826895
[TBL] [Abstract][Full Text] [Related]
12. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.
Yen MC; Lin CC; Chen YL; Huang SS; Yang HJ; Chang CP; Lei HY; Lai MD
Clin Cancer Res; 2009 Jan; 15(2):641-9. PubMed ID: 19147770
[TBL] [Abstract][Full Text] [Related]
13. Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells.
Yu G; Fang M; Gong M; Liu L; Zhong J; Feng W; Xiong P; Wang CY; Gong F
Transpl Immunol; 2008 Jan; 18(3):208-19. PubMed ID: 18047928
[TBL] [Abstract][Full Text] [Related]
14. Indoleamine 2,3-dioxygenase expression and functional activity in dendritic cells exposed to cholera toxin.
Slavica L; Nurkkala-Karlsson M; Karlson T; Ingelsten M; Nyström J; Eriksson K
Scand J Immunol; 2012 Aug; 76(2):113-22. PubMed ID: 22519828
[TBL] [Abstract][Full Text] [Related]
15. COX-2 and PGE2 signaling is essential for the regulation of IDO expression by curcumin in murine bone marrow-derived dendritic cells.
Jung ID; Jeong YI; Lee CM; Noh KT; Jeong SK; Chun SH; Choi OH; Park WS; Han J; Shin YK; Kim HW; Yun CH; Park YM
Int Immunopharmacol; 2010 Jul; 10(7):760-8. PubMed ID: 20399909
[TBL] [Abstract][Full Text] [Related]
16. A potential role for indoleamine 2,3-dioxygenase (IDO) in Rhodococcus equi infection.
Heller MC; Drew CP; Jackson KA; Griffey S; Watson JL
Vet Immunol Immunopathol; 2010 Dec; 138(3):174-82. PubMed ID: 20739070
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase.
Funeshima N; Fujino M; Kitazawa Y; Hara Y; Hara Y; Hayakawa K; Okuyama T; Kimura H; Li XK
J Gene Med; 2005 May; 7(5):565-75. PubMed ID: 15543532
[TBL] [Abstract][Full Text] [Related]
18. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction.
Matteoli G; Mazzini E; Iliev ID; Mileti E; Fallarino F; Puccetti P; Chieppa M; Rescigno M
Gut; 2010 May; 59(5):595-604. PubMed ID: 20427394
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell maturation with poly(I:C)-based versus PGE2-based cytokine combinations results in differential functional characteristics relevant to clinical application.
Möller I; Michel K; Frech N; Burger M; Pfeifer D; Frommolt P; Veelken H; Thomas-Kaskel AK
J Immunother; 2008 Jun; 31(5):506-19. PubMed ID: 18463533
[TBL] [Abstract][Full Text] [Related]
20. Tolerogenic dendritic cells transferring hyporesponsiveness and synergizing T regulatory cells in transplant tolerance.
Li M; Zhang X; Zheng X; Lian D; Zhang ZX; Sun H; Suzuki M; Vladau C; Huang X; Xia X; Zhong R; Garcia B; Min WP
Int Immunol; 2008 Feb; 20(2):285-93. PubMed ID: 18182381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]